Heartburn drugs linked to higher risk of gastroenteritis Taking acid suppressing drugs, such as proton pump inhibitors (PPIs), is linked with increased risk of developing bacterial gastroenteritis, results from a population-based study show.…
The Pharmaceutical Journal’s best of 2016: top news stories A round up of the most popular news stories of 2016.…
Proton pump inhibitors may increase risk of first stroke Data from 244,679 patients that had undergone endoscopy show that stroke incidence was 19% higher in patients who filed a prescription for a PPI compared with those with no PPI exposure…
The Pharmaceutical Journal’s most read opinion pieces of 2016A round up of the most popular opinion pieces of 2016.…
Most popular features of 2016 from The Pharmaceutical Journal Dawn Connelly describes the most popular features and infographics published in 2016.…
Irritable bowel syndrome drug given green light for use in Europe The European Commission has granted a marketing authorisation to a first-in-class treatment for irritable bowel syndrome (IBS) called eluxadoline (Truberzi) for use in the EU.…
Constipation treatment could lengthen cancer survival Study findings support a role for the mu opioid receptor in cancer progression.…
Community pharmacy could detect unknown cases of coeliac disease A proof of concept study has shown how opportunistic testing in community pharmacies may help identify those with coeliac disease who would not otherwise have been tested.…
Probiotics correct immune function in babies at risk of allergy In children who received a probiotic at birth, some functional characteristics of regulatory T cells improved, study finds.…
Time to halt the overprescribing of proton pump inhibitors Inappropriate use of proton pump inhibitors can cause a range of side effects and even harm to patients.…
